Bangladesh vs Jamaica: Access to anti-retroviral drugs, male
Bangladesh
45.0%
in 2024
Jamaica
47.0%
in 2024
Bangladesh rank
125th
Jamaica rank
122nd
Access to anti-retroviral drugs, male over time
- Bangladesh
- Jamaica
How they compare
Jamaica currently reports 47.0% against 45.0% in Bangladesh, a difference of 2.0%.
Across all 25 years both countries report, Jamaica has been ahead every year.
Bangladesh ranks 125th and Jamaica ranks 122nd of 141 countries.
Jamaica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.9% | 4.2% | 3.3% | Jamaica |
| 2010s | 13.0% | 29.1% | 16.1% | Jamaica |
| 2020s | 36.4% | 43.8% | 7.4% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Bangladesh or Jamaica?
- Jamaica, at 47.0% against 45.0% in Bangladesh as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Bangladesh and Jamaica?
- 2.0%, with Jamaica ahead.
- How many years of comparable data are there for Bangladesh and Jamaica?
- 25 years are reported by both, from 2000 to 2024.
- How do Bangladesh and Jamaica rank globally for access to anti-retroviral drugs, male?
- Bangladesh ranks 125th and Jamaica ranks 122nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.